39
Participants
Start Date
December 21, 2018
Primary Completion Date
June 3, 2022
Study Completion Date
June 3, 2022
Arterial blood sampling
All patients will have arterial blood sampling to assess pre-filter and post-filter plasma endotoxin mass and activity and plasma cytokine levels
Ultrafiltrate sampling
All patients will have ultrafiltrate sampling to assess cytokine levels
CVVH using oXiris™ filter
Patients included in the experimental arm will have renal replacement therapy by performing CVVH using oXiris™ filter
CVVH using PrismafleX HF1400 filter
Patients included in the experimental arm will have renal replacement therapy by performing CVVH using PrismafleX HF1400 filter
CHU Francois Mitterrand, Dijon
CHU Dijon - Bocage central, Dijon
Hopital Haut Lévèque - CHU Bordeaux, Pessac
Hopital Universitaire de Clermont Ferrand, Clermont-Ferrand
Anesthesia and Critical Care Medicine Department - Edouard Herriot Hospital, Lyon
Clinique de la Sauvegarde, Lyon
L'Hôpital Nord-Ouest - Villefranche sur Saone, Gleizé
Hôpital Pasteur 2 - Hôpital Universitaire de Nice, Nice
Baxter Healthcare Corporation
INDUSTRY
Hospices Civils de Lyon
OTHER